Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00661_DB01218_nanopub.RA0yo8woFLwWTl8JKK35XZsMYlUxwG4bHN3--MIH0isfw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00661_DB01218 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00661_DB01218 label "DDI between Verapamil and Halofantrine - Verapamil, a moderate CYP3A4 inhibitor, may increase the serum concentration of Halofantrine by decreasing its metabolism. Extreme caution with increased cardiac status monitoring should be used during concomitant therapy. [drugbank_resource:DB00661_DB01218]" assertion.
- drugbank_resource:DB00661_DB01218 identifier "drugbank_resource:DB00661_DB01218" assertion.
- drugbank_resource:DB00661_DB01218 title "DDI between Verapamil and Halofantrine - Verapamil, a moderate CYP3A4 inhibitor, may increase the serum concentration of Halofantrine by decreasing its metabolism. Extreme caution with increased cardiac status monitoring should be used during concomitant therapy." assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB01218 assertion.
- drugbank:DB01218 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB01218 assertion.